Adaptation is mandatory for intensity modulated proton therapy of advanced lung cancer to ensure target coverage

Background and purpose: large anatomical changes during radiotherapy are seen for a large proportion of lung cancer patients. We investigate the applicability of a decision support protocol for photon therapy in a proton therapy setting. Material and methods: twenty-three consecutive NSCLC patients...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hoffmann, Lone (VerfasserIn) , Alber, Markus (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2017
In: Radiotherapy and oncology
Year: 2016, Jahrgang: 122, Heft: 3, Pages: 400-405
ISSN:1879-0887
DOI:10.1016/j.radonc.2016.12.018
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1016/j.radonc.2016.12.018
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0167814016344590
Volltext
Verfasserangaben:Lone Hoffmann, Markus Alber, Maria Fuglsang Jensen, Marianne Ingerslev Holt, Ditte Sloth Møller

MARC

LEADER 00000caa a2200000 c 4500
001 1574302477
003 DE-627
005 20220814135054.0
007 cr uuu---uuuuu
008 180509r20172016xx |||||o 00| ||eng c
024 7 |a 10.1016/j.radonc.2016.12.018  |2 doi 
035 |a (DE-627)1574302477 
035 |a (DE-576)504302477 
035 |a (DE-599)BSZ504302477 
035 |a (OCoLC)1341009361 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hoffmann, Lone  |e VerfasserIn  |0 (DE-588)115868536X  |0 (DE-627)1020750111  |0 (DE-576)504302345  |4 aut 
245 1 0 |a Adaptation is mandatory for intensity modulated proton therapy of advanced lung cancer to ensure target coverage  |c Lone Hoffmann, Markus Alber, Maria Fuglsang Jensen, Marianne Ingerslev Holt, Ditte Sloth Møller 
264 1 |c 2017 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Available online 31 December 2016 
500 |a Gesehen am 09.05.2018 
520 |a Background and purpose: large anatomical changes during radiotherapy are seen for a large proportion of lung cancer patients. We investigate the applicability of a decision support protocol for photon therapy in a proton therapy setting. Material and methods: twenty-three consecutive NSCLC patients treated with adaptive photon therapy were retrospectively planned using IMPT. The adaptive protocol was based on geometrical measures of target positioning and large anatomical changes as shown on daily CBCT scans. Two surveillance CT-scans were acquired during the treatment course. The consequences of anatomical changes were evaluated by recalculating the proton plans on the surveillance scans. The CTV receiving 95% of the prescribed dose was analysed. Results: fourteen (61%) patients needed adaptations when treated with protons, given that 95% of the CTV must be covered by 95% of the dose. In comparison, no patients needed adaptation when treated with photons using this criterion. The adaptive protocol was found to identify patients with large target under-dosage for proton therapy (six patients). Additionally, target under-dosage was observed for eight patients with non-rigid changes up to 15mm in the positioning of the bones. Conclusions: proton therapy for loco-regional lung cancer demands daily imaging and therapy adaptation for a high proportion of patients. 
534 |c 2016 
650 4 |a Adaptation 
650 4 |a IMPT 
650 4 |a NSCLC 
650 4 |a Proton therapy 
700 1 |a Alber, Markus  |e VerfasserIn  |0 (DE-588)1145057101  |0 (DE-627)1005461767  |0 (DE-576)495602507  |4 aut 
773 0 8 |i Enthalten in  |t Radiotherapy and oncology  |d Amsterdam [u.a.] : Elsevier Science, 1983  |g 122(2017), 3, Seite 400-405  |h Online-Ressource  |w (DE-627)306710110  |w (DE-600)1500707-8  |w (DE-576)082435731  |x 1879-0887  |7 nnas  |a Adaptation is mandatory for intensity modulated proton therapy of advanced lung cancer to ensure target coverage 
773 1 8 |g volume:122  |g year:2017  |g number:3  |g pages:400-405  |g extent:6  |a Adaptation is mandatory for intensity modulated proton therapy of advanced lung cancer to ensure target coverage 
856 4 0 |u http://dx.doi.org/10.1016/j.radonc.2016.12.018  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0167814016344590  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180509 
993 |a Article 
994 |a 2017 
998 |g 1145057101  |a Alber, Markus  |m 1145057101:Alber, Markus  |d 910000  |d 911400  |e 910000PA1145057101  |e 911400PA1145057101  |k 0/910000/  |k 1/910000/911400/  |p 2 
999 |a KXP-PPN1574302477  |e 3008878202 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"display":"Hoffmann, Lone","family":"Hoffmann","role":"aut","given":"Lone"},{"display":"Alber, Markus","family":"Alber","given":"Markus","role":"aut"}],"note":["Available online 31 December 2016","Gesehen am 09.05.2018"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"2017"}],"title":[{"title_sort":"Adaptation is mandatory for intensity modulated proton therapy of advanced lung cancer to ensure target coverage","title":"Adaptation is mandatory for intensity modulated proton therapy of advanced lung cancer to ensure target coverage"}],"language":["eng"],"physDesc":[{"extent":"6 S."}],"name":{"displayForm":["Lone Hoffmann, Markus Alber, Maria Fuglsang Jensen, Marianne Ingerslev Holt, Ditte Sloth Møller"]},"recId":"1574302477","id":{"doi":["10.1016/j.radonc.2016.12.018"],"eki":["1574302477"]},"relHost":[{"id":{"issn":["1879-0887"],"eki":["306710110"],"zdb":["1500707-8"]},"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["1.1983 -"],"recId":"306710110","note":["Gesehen am 30.05.15","Ungezählte Beil.: Supplement"],"origin":[{"dateIssuedKey":"1983","publisher":"Elsevier Science","publisherPlace":"Amsterdam [u.a.]","dateIssuedDisp":"1983-"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"The green journal"}],"title":[{"subtitle":"journal of the European Society for Therapeutic Radiology and Oncology","title_sort":"Radiotherapy and oncology","title":"Radiotherapy and oncology"}],"part":{"year":"2017","pages":"400-405","text":"122(2017), 3, Seite 400-405","extent":"6","volume":"122","issue":"3"},"language":["eng"],"disp":"Adaptation is mandatory for intensity modulated proton therapy of advanced lung cancer to ensure target coverageRadiotherapy and oncology"}]} 
SRT |a HOFFMANNLOADAPTATION2017